Gut Microbiota Composition Before and After Use of Proton Pump Inhibitors
Open accessThe DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Recently, problems associated with proton pump inhibitor (PPI) use have begun to surface. PPIs influence the gut microbiota; therefore, PPI use may increase the risk of enteric infections and cause bacterial translocation. In this study, we investigated fecal microbiota composition, fecal organic acid concentrations and pH, and gut bacteria in the blood of the same patients before and after PPI use. METHODS: Twenty patients with reflux esophagitis based on endoscopic examination received 8 weeks of treatment with PPIs. To analyze fecal microbiota composition and gut bacteria in blood and organic acid concentrations, 16S and 23S rRNA-targeted quantitative RT-PCR and high-performance liquid chromatography were conducted. RESULTS: Lactobacillus species were significantly increased at both 4 and 8 weeks after PPI treatment compared with bacterial counts before treatment (P = 0.011 and P = 0.002, respectively). Among Lactobacillus spp., counts of the L. gasseri subgroup, L. fermentum, the L. reuteri subgroup, and the L. ruminis subgroup were significantly increased at 4 and 8 weeks after treatment compared with counts before treatment. Streptococcus species were also significantly increased at 4 and 8 weeks after PPI treatment compared with counts before treatment (P < 0.01 and P < 0.001, respectively). There was no significant difference in the total organic acid concentrations before and after PPI treatment. Detection rates of bacteria in blood before and after PPI treatment were 22 and 28%, respectively, with no significant differences. CONCLUSIONS: Our quantitative RT-PCR results showed that gut dysbiosis was caused by PPI use, corroborating previous results obtained by metagenomic analysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of note, antibiotics (except vancomycin),4”
From Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome (2024) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823 · cited 1×
“Recently, bacterial rRNA gene-based, metagenomic analyses have been conducted to analyze the composition of the human gut microbiome [22, 23, 42, 43].”
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762 · cited 1×
“Recently, bacterial rRNA gene-based, metagenomic analyses have been conducted to analyze the composition of the human gut microbiome [22, 23, 42, 43].”
Lundell, L. R., Dent, J., Bennett, J. R., Blum, A. L., Armstrong, D., Galmiche, J. P., Johnson, F., Hongo, M., Richter, J. E., Spechler, S. J., et al. (1999) · Gut · doi:10.1136/gut.45.2.172 · Cited by 2,305 · cited 1×
“All patients were at least 20 years of age and had been shown to have ≥ grade A reflux esophagitis according to the Los Angeles classification [31] by endoscopic examination within 6 months prior to recruitment.”
Control of pathogens and pathobionts by the gut microbiota
Kamada, N., Chen, G. Y., Inohara, N., & Núñez, G. (2013) · Nature Immunology · doi:10.1038/ni.2608 · Cited by 1,625 · cited 1×
“The gut microbiota plays an important role in host resistance against colonization by exogenous enteric microbes and overgrowth of indigenous commensals [18].”
Proton pump inhibitors affect the gut microbiome
Imhann, F., Bonder, M. J., Vich Vila, A., Fu, J., Mujagic, Z., Vork, L., Tigchelaar, E. F., Jankipersadsing, S. A., Cenit, M. C., Harmsen, H. J. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310376 · Cited by 1,371 · cited 14×
“Previous large cohort studies of PPI users and intervention studies of PPI use for 4 weeks reported increases in bacteria from the genus Streptococcus [19, 20, 22, 23].”
InfluentialMicroorganisms with Claimed Probiotic Properties: An Overview of Recent Literature
Fijan, S. (2014) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph110504745 · Cited by 1,059 · cited 1×
“The biological effects of probiotics are strain specific [58], and whether these bacteria have probiotic features is determined by a coevolutionary relationship between the bacteria and their hosts [59].”
Proton pump inhibitors alter the composition of the gut microbiota
Jackson, M. A., Goodrich, J. K., Maxan, M.-E., Freedberg, D. E., Abrams, J. A., Poole, A. C., Sutter, J. L., Welter, D., Ley, R. E., Bell, J. T., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310861 · Cited by 895 · cited 14×
“Previous large cohort studies of PPI users and intervention studies of PPI use for 4 weeks reported increases in bacteria from the genus Streptococcus [19, 20, 22, 23].”
InfluentialMatsuki, T., Watanabe, K., Fujimoto, J., Miyamoto, Y., Takada, T., Matsumoto, K., Oyaizu, H., & Tanaka, R. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.11.5445-5451.2002 · Cited by 657
Self-citationMatsuki, T., Watanabe, K., Fujimoto, J., Takada, T., & Tanaka, R. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.12.7220-7228.2004 · Cited by 655
Systematic review of the risk of enteric infection in patients taking acid suppression
Leonard, J., Marshall, J. K., & Moayyedi, P. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01275.x · Cited by 633
Cited by
Items 101–115 of 115
Li, X.-B., Chu, X.-J., Cao, N.-W., Wang, H., Fang, X.-Y., Fan, Y.-G., Li, B.-Z., & Dongqing, Y. E. (2022) · Figshare · doi:10.6084/m9.figshare.19669867
Li, X.-B., Chu, X.-J., Cao, N.-W., Wang, H., Fang, X.-Y., Fan, Y.-G., Li, B.-Z., & Dongqing, Y. E. (2022) · Figshare · doi:10.6084/m9.figshare.19669873
Zhang, J., Zhang, C., Zhang, Q., Yu, L., Chen, W., Xue, Y., & Zhai, Q. (2023) · Figshare · doi:10.6084/m9.figshare.23542924
Li, X.-B., Chu, X.-J., Cao, N.-W., Wang, H., Fang, X.-Y., Fan, Y.-G., Li, B.-Z., & Dongqing, Y. E. (2022) · Figshare · doi:10.6084/m9.figshare.19669876
Li, X.-B., Chu, X.-J., Cao, N.-W., Wang, H., Fang, X.-Y., Fan, Y.-G., Li, B.-Z., & Dongqing, Y. E. (2022) · Figshare · doi:10.6084/m9.figshare.19669870
Dinesh, D., Morgan, X. C., Kim, H., Scott, T. M., Garelnabi, M., Lee, J. S., Mangano, K. M., Nguyen, L. H., Huttenhower, C., Tucker, K. L., et al. (2025) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70205
Chronic Bacterial and Sicca Laryngitis: A Retrospective Cohort and Systematic Review
Howser, L. A., Shah, A. H., Curtis, C. J., Nguyen, S. A., Brown, J. M., & Meenan, K. D. (2025) · Annals of Otology Rhinology & Laryngology · doi:10.1177/00034894251405127
“32 Discontinuation of unnecessary long-term PPI therapy may be a useful consideration in treatment planning.”
Impact of proton pump inhibitor use on microbiota and diversity
Alsharef, A. S., Alsaedi, E. A. H., Almohmmadi, G. T., Alahmadi, K., Alhemshy, L. Z., Albugami, M. K., Alghanim, W. S., Alharbi, S. S., Alahmadi, Y. K., Aljohani, Y. S., et al. (2025) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20254453
Völkerer, A., Wernly, S., Semmler, G., Flamm, M., Ausserwinkler, M., Koch, G., Götz, N., Hofer, H., Aigner, E., Datz, C., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-37547-2
Wang, J., Zhao, Y., Zhang, Y., Chen, J., Wu, H., & Fang, H. (2026) · International Journal of COPD · doi:10.2147/copd.s572455
Role du microbiote intestinal et avec anticorps anti-PD1 induit immunesurveillance du cancer du rein
Derosa, L. (2019) · theses.fr (ABES) · doi:10.70675/e3d7f456z3645z487az8659zc864d2b57698 · Cited by 1
Composition and diversity of gut microbiota in non-erosive reflux disease
Wei, X., Wang, G., Wei, Y., Zhang, T., Lu, M., Xu, L., Zhang, B., & Tang, X. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1795756
“However, the research by Hojo et al. (2018) noted an increase in Lactobacillus with PPIs use, consistent with our results.”
Zanoni, A., Facchin, S., Mari, V., Bertin, L., & Savarino, E. V. (2026) · Pharmaceuticals · doi:10.3390/ph19050705
“In fecal samples have been observed within 4–8 weeks of therapy [25,102].”
El-Tahir, R., Qureshi, S., Ashfaq, N., Sikandar, S., Omar, S., Shah, P., & Bitar, E. (2026) · Open Journal of Internal Medicine · doi:10.4236/ojim.2026.163028
Li, L.-C., Cui, W.-H., Zhang, Z., Song, J., Xu, Y., Cai, D.-G., Guan, Y., & Mao, K.-L. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1900027
Metadata
- Authors
- Hojo, M., Asahara, T., Nagahara, A., Takeda, T., Matsumoto, K., Ueyama, H., Matsumoto, K., Asaoka, D., Takahashi, T., Nomoto, K., Yamashiro, Y., & Watanabe, S.
- Affiliations
- Juntendo University (JP)
- Juntendo Tokyo Koto Geriatric Medical Center (JP)
- Tokyo University of Agriculture (JP)
- Corresponding author
- Hojo, Mariko
- ORCID
- Venue
- Digestive Diseases and Sciences
- Published
- 2018-05-24
- Volume
- 63
- Issue
- 11
- Pages
- 2940-2949
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- PMC
- PMC6182435
- OpenAlex
- W2804467228
- Cited by
- 114
- References
- 62
- Citations by year
- 2026: 11 · 2025: 12 · 2024: 12 · 2023: 15 · 2022: 11 · 2021: 28 · 2020: 15 · 2019: 8 · 2018: 1
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0 (tdm)
- Locations
- Digestive Diseases and Sciences (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Yakult Honsha
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
- Keywords
- proton pump inhibitors, gut microbiota, reflux esophagitis, gut dysbiosis, Lactobacillus, Streptococcus, fecal pH, bacterial translocation, gastrointestinal infections, Lactobacillus gasseri, Lactobacillus fermentum, Lactobacillus reuteri, Lactobacillus ruminis
- MeSH terms
- Gastrointestinal Microbiome, Aged, Blood, Carboxylic Acids, Feces, Female, Humans, Male, Middle Aged, Proton Pump Inhibitors, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
